Spherical Nucleic Acids Deliver a New Package for Oliognucleotide Therapeutics
SNAs Are a Hopeful First Step in Boosting the Utility of Oligonucleotides to Treat a Variety of Human Diseases
Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
For full access to this article login to GEN Select now.
Setting Sights on Ocular Disorders
New Therapeutic Options Are in Development for Age-Related Macular Degeneration
- Age-related macular degeneration (AMD) is one of the leading causes of blindness. There are two forms of AMD—wet and dry. Currently, the majority of therapeutics being developed are for wet AMD ( Figure ). The standard therapy for wet AMD is anti-VEGF injections. The benefit of these injections ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.